Next Article in Journal

2-Substituted-3-(5-Substituted-1,3,4-oxadiazol/thiadiazol-2-yl) Thiazolidin-4-one Derivatives: Synthesis, Anticancer, Antimicrobial, and Antioxidant Potential

Previous Article in Journal

Design, Synthesis, Biological Evaluation, and Molecular Docking Study of 4,6-Dimethyl-5-aryl/alkyl-2-[2-hydroxy-3-(4-substituted-1-piperazinyl)propyl]pyrrolo[3,4-c]pyrrole-1,3(2H,5H)-diones as Anti-Inflammatory Agents with Dual Inhibition of COX and LOX

Previous Article in Special Issue

A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessArticle

Article Versions Notes

Pharmaceuticals 2023, 16(6), 803; https://doi.org/10.3390/ph16060803

Action	Date	Notes	Link
article html file updated	11 September 2025 21:56 CEST	Update	https://www.mdpi.com/1424-8247/16/6/803/html
article html file updated	6 September 2025 08:48 CEST	Update	-
article html file updated	22 August 2025 22:17 CEST	Update	-
article html file updated	29 May 2023 13:14 CEST	Original file	-
article supplementary file uploaded.	29 May 2023 13:13 CEST	-	https://www.mdpi.com/1424-8247/16/6/803#supplementary
article pdf uploaded.	29 May 2023 13:13 CEST	Version of Record	https://www.mdpi.com/1424-8247/16/6/803/pdf
article xml uploaded.	29 May 2023 13:13 CEST	Update	https://www.mdpi.com/1424-8247/16/6/803/xml
article xml file uploaded	29 May 2023 13:13 CEST	Original file	-

Back to TopTop